Insight Report 2 minutes PremiumRite Aid (RAD) 2Q17 RESULTS: ACQUISITION ON TRACK TO CLOSE IN 2H16 Coresight Research September 23, 2016 Executive Summary Rite Aid reported adjusted EPS of $0.03, beating the $0.02 consensus estimate and up from last year’s $0.02. Businesses that contributed to the positive results included its EnvisionRX PBM, and its strong front-end segment. There was some improvement in prescription drug costs, which was offset by challenging reimbursement rates. The company continues to believe that the announced acquisition of Rite Aid by Walgreens will close in the second half of 2016. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: RFID in Fashion: Higher Penetration and More Advancements on the HorizonInnovator Profile: PSYKHE AI Accurately Predicts Purchasing Behavior Using Deep-Learning ModelsShoptalk Europe 2023 Day One: Identifying Real Value in Sustainability, Generative AI and DataEarnings Insights 1Q24, Week 1: L’Oréal and Skechers Report Positive Sales Growth, Columbia Sportswear and Levi’s Post Sales Declines
